These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 22632623)

  • 1. Glutamatergic effects of divalproex in adolescents with mania: a proton magnetic resonance spectroscopy study.
    Strawn JR; Patel NC; Chu WJ; Lee JH; Adler CM; Kim MJ; Bryan HS; Alfieri DC; Welge JA; Blom TJ; Nandagopal JJ; Strakowski SM; DelBello MP
    J Am Acad Child Adolesc Psychiatry; 2012 Jun; 51(6):642-51. PubMed ID: 22632623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anterior Cingulate Cortex Glutamatergic Metabolites and Mood Stabilizers in Euthymic Bipolar I Disorder Patients: A Proton Magnetic Resonance Spectroscopy Study.
    Soeiro-de-Souza MG; Otaduy MCG; Machado-Vieira R; Moreno RA; Nery FG; Leite C; Lafer B
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2018 Dec; 3(12):985-991. PubMed ID: 29789269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mania, glutamate/glutamine and risperidone in pediatric bipolar disorder: a proton magnetic resonance spectroscopy study of the anterior cingulate cortex.
    Moore CM; Biederman J; Wozniak J; Mick E; Aleardi M; Wardrop M; Dougherty M; Harpold T; Hammerness P; Randall E; Lyoo IK; Renshaw PF
    J Affect Disord; 2007 Apr; 99(1-3):19-25. PubMed ID: 17005256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurochemical effects of olanzapine in first-hospitalization manic adolescents: a proton magnetic resonance spectroscopy study.
    DelBello MP; Cecil KM; Adler CM; Daniels JP; Strakowski SM
    Neuropsychopharmacology; 2006 Jun; 31(6):1264-73. PubMed ID: 16292323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurochemical effects of quetiapine in patients with bipolar mania: a proton magnetic resonance spectroscopy study.
    Adler CM; DelBello MP; Weber WA; Jarvis KB; Welge J; Chu WJ; Rummelhoff E; Kim MJ; Lee JH; Strakowski SM
    J Clin Psychopharmacol; 2013 Aug; 33(4):528-32. PubMed ID: 23764689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in brain Glx in depressed bipolar patients treated with lamotrigine: A proton MRS study.
    Godlewska BR; Emir UE; Masaki C; Bargiotas T; Cowen PJ
    J Affect Disord; 2019 Mar; 246():418-421. PubMed ID: 30599363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurochemical alterations in adolescent bipolar depression: a proton magnetic resonance spectroscopy pilot study of the prefrontal cortex.
    Patel NC; Cecil KM; Strakowski SM; Adler CM; DelBello MP
    J Child Adolesc Psychopharmacol; 2008 Dec; 18(6):623-7. PubMed ID: 19108667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind, randomized, placebo-controlled trial of divalproex extended-release in the treatment of bipolar disorder in children and adolescents.
    Wagner KD; Redden L; Kowatch RA; Wilens TE; Segal S; Chang K; Wozniak P; Vigna NV; Abi-Saab W; Saltarelli M
    J Am Acad Child Adolesc Psychiatry; 2009 May; 48(5):519-532. PubMed ID: 19325497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents.
    Geller B; Luby JL; Joshi P; Wagner KD; Emslie G; Walkup JT; Axelson DA; Bolhofner K; Robb A; Wolf DV; Riddle MA; Birmaher B; Nusrat N; Ryan ND; Vitiello B; Tillman R; Lavori P
    Arch Gen Psychiatry; 2012 May; 69(5):515-28. PubMed ID: 22213771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lithium and valproic acid treatment effects on brain chemistry in bipolar disorder.
    Friedman SD; Dager SR; Parow A; Hirashima F; Demopulos C; Stoll AL; Lyoo IK; Dunner DL; Renshaw PF
    Biol Psychiatry; 2004 Sep; 56(5):340-8. PubMed ID: 15336516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder.
    Kowatch RA; Suppes T; Carmody TJ; Bucci JP; Hume JH; Kromelis M; Emslie GJ; Weinberg WA; Rush AJ
    J Am Acad Child Adolesc Psychiatry; 2000 Jun; 39(6):713-20. PubMed ID: 10846305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutamatergic Correlates of Bipolar Symptoms in Adolescents.
    Sonmez AI; Lewis CP; Port JD; Cabello-Arreola A; Blacker CJ; Seewoo BJ; McKean AJ; Leffler JM; Frye MA; Croarkin PE
    J Child Adolesc Psychopharmacol; 2020 Dec; 30(10):599-605. PubMed ID: 33179961
    [No Abstract]   [Full Text] [Related]  

  • 13. Double-blind randomized trial of risperidone versus divalproex in pediatric bipolar disorder: fMRI outcomes.
    Pavuluri MN; Passarotti AM; Lu LH; Carbray JA; Sweeney JA
    Psychiatry Res; 2011 Jul; 193(1):28-37. PubMed ID: 21592741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
    Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA
    J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bcl-2 rs956572 polymorphism is associated with increased anterior cingulate cortical glutamate in euthymic bipolar I disorder.
    Soeiro-de-Souza MG; Salvadore G; Moreno RA; Otaduy MC; Chaim KT; Gattaz WF; Zarate CA; Machado-Vieira R
    Neuropsychopharmacology; 2013 Feb; 38(3):468-75. PubMed ID: 23072837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, placebo-controlled, multicenter study of divalproex sodium extended-release in the acute treatment of mania.
    Hirschfeld RM; Bowden CL; Vigna NV; Wozniak P; Collins M
    J Clin Psychiatry; 2010 Apr; 71(4):426-32. PubMed ID: 20361904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased anterior cingulate/medial prefrontal cortical glutamate and creatine in bipolar depression.
    Frye MA; Watzl J; Banakar S; O'Neill J; Mintz J; Davanzo P; Fischer J; Chirichigno JW; Ventura J; Elman S; Tsuang J; Walot I; Thomas MA
    Neuropsychopharmacology; 2007 Dec; 32(12):2490-9. PubMed ID: 17429412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium.
    Scheffer RE; Kowatch RA; Carmody T; Rush AJ
    Am J Psychiatry; 2005 Jan; 162(1):58-64. PubMed ID: 15625202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term safety of divalproex sodium extended-release in children and adolescents with bipolar I disorder.
    Redden L; DelBello M; Wagner KD; Wilens TE; Malhotra S; Wozniak P; Vigna NV; Greco N; Kovacs X; Abi-Saab W; Saltarelli M;
    J Child Adolesc Psychopharmacol; 2009 Feb; 19(1):83-9. PubMed ID: 19232026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1H-magnetic resonance spectroscopy study of glutamate-related abnormality in bipolar disorder.
    Kubo H; Nakataki M; Sumitani S; Iga JI; Numata S; Kameoka N; Watanabe SY; Umehara H; Kinoshita M; Inoshita M; Tamaru M; Ohta M; Nakayama-Yamauchi C; Funakoshi Y; Harada M; Ohmori T
    J Affect Disord; 2017 Jan; 208():139-144. PubMed ID: 27770643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.